Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7605238 Human CTLA-4 antibodies and their uses

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Tibor P. Keler0

Alan J. Korman0

Edward L. Halk0

Nils Lonberg0

Yashwant M. Deo0

Date of Patent

October 20, 2009

Patent Application Number

09948939

Date Filed

September 7, 2001

Patent Citations Received

0

US Patent 12084655 Packaging oligonucleotides into virus-like particles

0

US Patent 11707056 Animals, repertoires and methods

0

US Patent 12090147 Combination therapy with 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

0

US Patent 12084518 Trispecific binding proteins and methods of use

0

US Patent 11827704 Antibody molecules to PD-1 and uses thereof

0

US Patent 11767361 Method of treating lung cancer

US Patent 11840571 Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4

0

...

Patent Primary Examiner

Patent abstract

The present invention provides human sequence antibodies against human CTLA-4 and methods of treating human diseases, infections and other conditions using these antibodies.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7605238 Human CTLA-4 antibodies and their uses

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool